• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙胺可改善患有精神分裂症的药物治疗个体以及健康志愿者的认知功能。

Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers.

作者信息

Barch Deanna M, Carter Cameron S

机构信息

Department of Psychology, Washington University, St. Louis, MO 63130, United States.

出版信息

Schizophr Res. 2005 Sep 1;77(1):43-58. doi: 10.1016/j.schres.2004.12.019.

DOI:10.1016/j.schres.2004.12.019
PMID:16005384
Abstract

BACKGROUND

Recent research on schizophrenia indicates that cognitive deficits in this illness are important predictors of functional outcome, highlighting the need for treatments that have a positive impact on cognitive function. Here we explore the hypothesis that acute administration of d-amphetamine can improve cognitive function in individuals with schizophrenia who are well-treated with typical antipsychotics, as well as in healthy controls performing under dual task conditions designed to elicit performance deficits analogous to those found in schizophrenia.

METHODS

Ten individuals with schizophrenia taking haldol or prolixin and 22 healthy controls performed spatial working memory, language production, and Stroop tasks under both placebo and 0.25 mg/kg of D-amphetamine.

RESULTS

D-Amphetamine improved reactions times on the spatial working memory and Stroop tasks for both individuals with schizophrenia and controls, and improved working memory accuracy in schizophrenia. In addition, D-amphetamine improved language production for both individuals with schizophrenia and controls.

CONCLUSIONS

These results provide support for the hypothesis that the adjunctive administration of dopamine agonist can improve cognitive in individuals with schizophrenia taking typical antipsychotics. The results are discussed in terms of their implications for understanding the nature of working memory deficits in schizophrenia, and potential future avenues for cognitive enhancement in this illness.

摘要

背景

近期关于精神分裂症的研究表明,该疾病中的认知缺陷是功能预后的重要预测指标,这凸显了对认知功能有积极影响的治疗方法的需求。在此,我们探讨这样一个假设:急性给予右旋苯丙胺能够改善使用典型抗精神病药物治疗效果良好的精神分裂症患者的认知功能,以及在旨在引发类似于精神分裂症患者所发现的表现缺陷的双重任务条件下执行任务的健康对照者的认知功能。

方法

10名正在服用氟哌啶醇或奋乃静的精神分裂症患者以及22名健康对照者在服用安慰剂和0.25mg/kg右旋苯丙胺的情况下,分别执行空间工作记忆、语言表达和斯特鲁普任务。

结果

右旋苯丙胺缩短了精神分裂症患者和对照者在空间工作记忆和斯特鲁普任务中的反应时间,并提高了精神分裂症患者工作记忆的准确性。此外,右旋苯丙胺改善了精神分裂症患者和对照者的语言表达能力。

结论

这些结果为多巴胺激动剂辅助给药可改善服用典型抗精神病药物的精神分裂症患者认知功能这一假设提供了支持。我们将根据这些结果对理解精神分裂症工作记忆缺陷的本质以及该疾病未来潜在的认知增强途径的意义进行讨论。

相似文献

1
Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers.苯丙胺可改善患有精神分裂症的药物治疗个体以及健康志愿者的认知功能。
Schizophr Res. 2005 Sep 1;77(1):43-58. doi: 10.1016/j.schres.2004.12.019.
2
Executive function in schizophrenia: what impact do antipsychotics have?精神分裂症中的执行功能:抗精神病药物有何影响?
Hum Psychopharmacol. 2007 Aug;22(6):397-406. doi: 10.1002/hup.861.
3
Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics.氯氮平、利培酮和传统抗精神病药物长期治疗精神分裂症的认知差异
Int Clin Psychopharmacol. 2015 Mar;30(2):89-95. doi: 10.1097/YIC.0000000000000066.
4
Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.长期苯二氮䓬类药物逐渐减量对接受第二代抗精神病药物治疗的精神分裂症患者认知功能的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):300-6. doi: 10.1016/j.pnpbp.2011.11.008. Epub 2011 Nov 21.
5
Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.精神分裂症患者的空间工作记忆与问题解决能力:非典型抗精神病药物稳定症状的影响
Psychiatry Res. 2008 Sep 30;160(3):316-26. doi: 10.1016/j.psychres.2007.07.011. Epub 2008 Jun 24.
6
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.莫达非尼可改善慢性精神分裂症患者的认知能力和注意力转换能力。
Neuropsychopharmacology. 2004 Jul;29(7):1363-73. doi: 10.1038/sj.npp.1300457.
7
Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects.安非他命相关的执行功能改善与慢性精神分裂症患者的练习效应有关。
Schizophr Res. 2010 Dec;124(1-3):176-82. doi: 10.1016/j.schres.2010.09.012. Epub 2010 Oct 13.
8
Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.利培酮对首发精神分裂症患者空间工作记忆的不良影响。
Arch Gen Psychiatry. 2006 Nov;63(11):1189-97. doi: 10.1001/archpsyc.63.11.1189.
9
Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.精神分裂症的执行注意缺陷:药物治疗的精神分裂症患者中假定的强制性和差异认知病理领域。
Psychiatry Res. 2013 Aug 30;209(1):1-8. doi: 10.1016/j.psychres.2012.09.057. Epub 2012 Oct 26.
10
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.一项关于多巴胺-1受体激动剂DAR-0100A用于改善精神分裂症认知功能的概念验证性随机对照试验。
J Psychopharmacol. 2016 May;30(5):428-35. doi: 10.1177/0269881116636120. Epub 2016 Mar 10.

引用本文的文献

1
Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling.挖掘高质量多巴胺转运体药理学数据的潜力:推进基于稳健机器学习的定量构效关系建模
bioRxiv. 2024 Mar 11:2024.03.06.583803. doi: 10.1101/2024.03.06.583803.
2
Combined electrochemistry and mass spectrometry imaging to interrogate the mechanism of action of modafinil, a cognition-enhancing drug, at the cellular and sub-cellular level.结合电化学和质谱成像技术,在细胞和亚细胞水平上探究莫达非尼(一种认知增强药物)的作用机制。
QRB Discov. 2021 Jul 2;2:e6. doi: 10.1017/qrd.2021.4. eCollection 2021.
3
The effects of caffeine and d-amphetamine on spatial span task in healthy participants.
咖啡因和 d-苯丙胺对健康参与者空间跨度任务的影响。
PLoS One. 2023 Jul 13;18(7):e0287538. doi: 10.1371/journal.pone.0287538. eCollection 2023.
4
Using Automated Speech Processing for Repeated Measurements in a Clinical Setting of the Behavioral Variability in the Stroop Task.在临床环境中,利用自动语音处理对斯特鲁普任务中的行为变异性进行重复测量。
Brain Sci. 2023 Mar 4;13(3):442. doi: 10.3390/brainsci13030442.
5
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.跨诊断认知功能的决定因素:毒蕈碱型乙酰胆碱受体作为一个模型系统。
Transl Psychiatry. 2023 Mar 27;13(1):100. doi: 10.1038/s41398-023-02400-x.
6
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment.精神分裂症认知障碍:病因、发病机制与治疗。
Mol Psychiatry. 2023 May;28(5):1902-1918. doi: 10.1038/s41380-023-01949-9. Epub 2023 Jan 23.
7
The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia.选择性黑质纹状体多巴胺过多对与精神分裂症认知和阴性症状相关的行为的影响。
Neuropsychopharmacology. 2023 Mar;48(4):690-699. doi: 10.1038/s41386-022-01492-1. Epub 2022 Nov 15.
8
Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits.系统评价安非他命对健康个体工作记忆和其他认知表现的急性影响,重点关注人格特质的潜在影响。
Hum Psychopharmacol. 2023 Jan;38(1):e2856. doi: 10.1002/hup.2856. Epub 2022 Oct 17.
9
MDMA for the Treatment of Negative Symptoms in Schizophrenia.摇头丸用于治疗精神分裂症的阴性症状。
J Clin Med. 2022 Jun 7;11(12):3255. doi: 10.3390/jcm11123255.
10
Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine.右旋苯丙胺前体药物赖右苯丙胺对大鼠运动、空间认知加工及神经化学特征的影响:与速释型苯丙胺的比较
Front Psychiatry. 2022 Apr 26;13:885574. doi: 10.3389/fpsyt.2022.885574. eCollection 2022.